Profound Medical Provides TULSA-PRO® Reimbursement Update
02 sept. 2022 12h05 HE
|
Profound Medical Corp.
TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Second Quarter 2022 Financial Results
04 août 2022 16h05 HE
|
Profound Medical Corp.
TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Second Quarter 2022 Financial Results on August 4 – Conference Call to Follow
14 juil. 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
16 juin 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2022 Jefferies Global Healthcare Conference
02 juin 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, June 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Annual and Special Meeting of Shareholders Voting Results
18 mai 2022 17h43 HE
|
Profound Medical Corp.
TORONTO, May 18, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual and Special Meeting...
Profound Medical Clarifies Recent Insider Buying
18 mai 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, May 18, 2022 (GLOBE NEWSWIRE) -- In response to investor inquiries regarding insider trading activity, particularly with respect to recent open market stock purchases made by certain of its...
TULSA-PRO® Was Front and Center at AUA2022
17 mai 2022 17h25 HE
|
Profound Medical Corp.
TORONTO, May 17, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces First Quarter 2022 Financial Results
09 mai 2022 16h05 HE
|
Profound Medical Corp.
TORONTO, May 09, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference
25 avr. 2022 16h30 HE
|
Profound Medical Corp.
TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...